Odysseus moon lander hailed as success as it nears mission-ending slumber By Reuters
[ad_1] © Reuters. FILE PHOTO: Intuitive Machines’ Odysseus spacecraft passes over the near side of the Moon following lunar orbit insertion on February 21, 2024,...
Brazil’s Suzano posts quarterly profit fall, swaps CEO after 11 years By Reuters
[ad_1] © Reuters. By Andre Romani and Patricia Vilas Boas SAO PAULO (Reuters) -Brazilian pulpmaker Suzano posted on Wednesday a 39% fall in its fourth-quarter...
Apple to disclose AI plans later this year, CEO Tim Cook says By Reuters
[ad_1] © Reuters. Apple logo is seen in this illustration taken, August 22, 2022. REUTERS/Dado Ruvic/Illustration By Stephen Nellis (Reuters) -Apple plans to disclose more...
Australia’s Star Entertainment beats interim profit estimate, shares jump By Reuters
[ad_1] © Reuters. FILE PHOTO: Visitors to Sydney’s Star Casino play electronic slot machines, February 15, 2016. REUTERS/Jason Reed/File Photo By Poonam Behura (Reuters) -Australian...
METALS-Copper held down by China’s property woes and strong dollar
By Eric Onstad LONDON, Feb 28 (Reuters) – Copper prices resumed their downward path on Wednesday, weighed down by a stronger dollar and more bad...
US stock futures fall on pressure from inflation jitters, Fed comments By Investing.com
[ad_1] © Reuters. Investing.com– U.S. stock index futures fell in evening deals on Wednesday, extending a decline in Wall Street as uncertainty over an upcoming...
US economy grew solid 3.2% in fourth quarter, a slight downgrade from government’s initial estimate
WASHINGTON (AP) — The U.S. economy grew at a robust 3.2% annual pace from October through December, propelled by healthy consumer spending, the Commerce Department...
US DOJ looking into Boeing’s door plug blowout, Bloomberg reports By Reuters
[ad_1] © Reuters. FILE PHOTO: National Transportation Safety Board (NTSB) investigators examine the fuselage plug area of Alaska Airlines Flight 1282 Boeing 737-9 MAX, which...
BioLineRx begins phase 2 trial for pancreatic cancer treatment By Investing.com
[ad_1] © Reuters. TEL AVIV – BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical company, has initiated the Phase 2 CheMo4METPANC clinical trial, dosing the...
Oil Edges Lower With US Stockpiles, OPEC+ Supply Policy in Focus
(Bloomberg) — Oil fell after trading in a narrow range as traders weighed rising US crude inventories against expectations that OPEC+ will extend supply cuts....